Brazil · Delayed Price · Currency is BRL Raia Drogasil Statistics
Total Valuation
Raia Drogasil has a market cap or net worth of BRL 29.92 billion. The enterprise value is 37.86 billion.
| Market Cap | 29.92B |
| Enterprise Value | 37.86B |
Important Dates
The last earnings date was Tuesday, August 4, 2026.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | Jul 6, 2026 |
Share Statistics
Raia Drogasil has 1.75 billion shares outstanding. The number of shares has decreased by -2.03% in one year.
| Current Share Class | 1.75B |
| Shares Outstanding | 1.75B |
| Shares Change (YoY) | -2.03% |
| Shares Change (QoQ) | -1.02% |
| Owned by Insiders (%) | 18.88% |
| Owned by Institutions (%) | 48.64% |
| Float | 1.31B |
Valuation Ratios
The trailing PE ratio is 20.13 and the forward PE ratio is 16.29. Raia Drogasil's PEG ratio is 0.72.
| PE Ratio | 20.13 |
| Forward PE | 16.29 |
| PS Ratio | 0.64 |
| PB Ratio | 4.10 |
| P/TBV Ratio | 5.70 |
| P/FCF Ratio | 18.37 |
| P/OCF Ratio | 9.90 |
| PEG Ratio | 0.72 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.68, with an EV/FCF ratio of 23.25.
| EV / Earnings | 28.20 |
| EV / Sales | 0.81 |
| EV / EBITDA | 7.68 |
| EV / EBIT | 12.66 |
| EV / FCF | 23.25 |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 1.18.
| Current Ratio | 1.41 |
| Quick Ratio | 0.48 |
| Debt / Equity | 1.18 |
| Debt / EBITDA | 1.74 |
| Debt / FCF | 5.28 |
| Interest Coverage | 2.56 |
Financial Efficiency
Return on equity (ROE) is 19.99% and return on invested capital (ROIC) is 17.38%.
| Return on Equity (ROE) | 19.99% |
| Return on Assets (ROA) | 7.80% |
| Return on Invested Capital (ROIC) | 17.38% |
| Return on Capital Employed (ROCE) | 20.34% |
| Weighted Average Cost of Capital (WACC) | 6.07% |
| Revenue Per Employee | 615,576 |
| Profits Per Employee | 17,758 |
| Employee Count | 75,594 |
| Asset Turnover | 1.94 |
| Inventory Turnover | 3.89 |
Taxes
In the past 12 months, Raia Drogasil has paid 165.58 million in taxes.
| Income Tax | 165.58M |
| Effective Tax Rate | 10.59% |
Stock Price Statistics
The stock price has increased by +3.58% in the last 52 weeks. The beta is 0.01, so Raia Drogasil's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | +3.58% |
| 50-Day Moving Average | 17.94 |
| 200-Day Moving Average | 21.59 |
| Relative Strength Index (RSI) | 44.82 |
| Average Volume (20 Days) | 9,780,065 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Raia Drogasil had revenue of BRL 46.53 billion and earned 1.34 billion in profits. Earnings per share was 0.81.
| Revenue | 46.53B |
| Gross Profit | 14.10B |
| Operating Income | 2.99B |
| Pretax Income | 1.56B |
| Net Income | 1.34B |
| EBITDA | 3.86B |
| EBIT | 2.99B |
| Earnings Per Share (EPS) | 0.81 |
Balance Sheet
The company has 652.95 million in cash and 8.59 billion in debt, with a net cash position of -7.94 billion or -4.54 per share.
| Cash & Cash Equivalents | 652.95M |
| Total Debt | 8.59B |
| Net Cash | -7.94B |
| Net Cash Per Share | -4.54 |
| Equity (Book Value) | 7.29B |
| Book Value Per Share | 4.17 |
| Working Capital | 4.12B |
Cash Flow
In the last 12 months, operating cash flow was 3.02 billion and capital expenditures -1.39 billion, giving a free cash flow of 1.63 billion.
| Operating Cash Flow | 3.02B |
| Capital Expenditures | -1.39B |
| Depreciation & Amortization | 872.71M |
| Net Borrowing | -1.22B |
| Free Cash Flow | 1.63B |
| FCF Per Share | 0.93 |
Margins
Gross margin is 30.30%, with operating and profit margins of 6.42% and 2.88%.
| Gross Margin | 30.30% |
| Operating Margin | 6.42% |
| Pretax Margin | 3.36% |
| Profit Margin | 2.88% |
| EBITDA Margin | 8.29% |
| EBIT Margin | 6.42% |
| FCF Margin | 3.50% |
Dividends & Yields
This stock pays an annual dividend of 0.39, which amounts to a dividend yield of 2.29%.
| Dividend Per Share | 0.39 |
| Dividend Yield | 2.29% |
| Dividend Growth (YoY) | 10.16% |
| Years of Dividend Growth | 12 |
| Payout Ratio | 54.12% |
| Buyback Yield | 2.03% |
| Shareholder Yield | 4.30% |
| Earnings Yield | 4.49% |
| FCF Yield | 5.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Raia Drogasil is 25.25, which is 42.49% higher than the current price. The consensus rating is "Buy".
| Price Target | 25.25 |
| Price Target Difference | 42.49% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 9.86% |
| EPS Growth Forecast (3Y) | 22.54% |
Stock Splits
The last stock split was on December 23, 2025. It was a forward split with a ratio of 1.02.
| Last Split Date | Dec 23, 2025 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Raia Drogasil has an Altman Z-Score of 3.82 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.82 |
| Piotroski F-Score | 7 |